Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients
Gespeichert in:
Veröffentlicht in: | Neurological sciences 2015-03, Vol.36 (3), p.489-491 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 491 |
---|---|
container_issue | 3 |
container_start_page | 489 |
container_title | Neurological sciences |
container_volume | 36 |
creator | Cordioli, Cinzia De Rossi, Nicola Rasia, Sarah Lodoli, Giovanni Capra, Ruggero |
description | |
doi_str_mv | 10.1007/s10072-014-1918-y |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1658378899</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3605295921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-af3382b3f898956a016e8679bc6e77e1451eec1c9b2faefed65be7f772c711913</originalsourceid><addsrcrecordid>eNp1kctu1TAQhi0EakvbB2CDLLGBRYonN9tLVJWLdCpY0LXlOOM2xYmD7RSFt-CN8VEOFZtuZkbyN_94_iHkFbALYIy_j_tYFgzqAiSIYn1GTqCRrKhqLp4fahC8PiYvY7xnLJNQHZHjsgEmBTQn5M-VDm6lPSY0afAT1VNPrX7wS9CdQ-qXZPyYs6WTTtoNv5dRd0VApxP2dA7-NmCMwwPScXFpsN5oRx0uPzxOBuc77fys091K33673r2jw0TTL7-xc9aPxmHwcYg0UwNOKZ6RF1a7iOeHfEpuPl59v_xc7L5--nL5YVeYui5ToW1VibKrrJBCNq1m0KJouexMi5wj1A0gGjCyK61Gi33bdMgt56XhkN2qTsmbTTfv8HPBmNR9XnrKIxW0jai4EFJmCjbK5F_GgFbNYRh1WBUwtbdfbUdQ2Vq1P4Jac8_rg_LSjdg_dvxzPQPlBsT8NN1i-G_0k6p_AXkNlpo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1658378899</pqid></control><display><type>article</type><title>Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Cordioli, Cinzia ; De Rossi, Nicola ; Rasia, Sarah ; Lodoli, Giovanni ; Capra, Ruggero</creator><creatorcontrib>Cordioli, Cinzia ; De Rossi, Nicola ; Rasia, Sarah ; Lodoli, Giovanni ; Capra, Ruggero</creatorcontrib><identifier>ISSN: 1590-1874</identifier><identifier>EISSN: 1590-3478</identifier><identifier>DOI: 10.1007/s10072-014-1918-y</identifier><identifier>PMID: 25109815</identifier><language>eng</language><publisher>Milan: Springer Milan</publisher><subject>Adult ; Brain - drug effects ; Brain - pathology ; Early Diagnosis ; Female ; Humans ; Letter to the Editor ; Leukoencephalopathy, Progressive Multifocal - chemically induced ; Leukoencephalopathy, Progressive Multifocal - diagnosis ; Medicine ; Medicine & Public Health ; Multiple Sclerosis, Relapsing-Remitting - complications ; Multiple Sclerosis, Relapsing-Remitting - drug therapy ; Natalizumab - adverse effects ; Natalizumab - therapeutic use ; Neurology ; Neuroradiology ; Neurosciences ; Neurosurgery ; Psychiatry</subject><ispartof>Neurological sciences, 2015-03, Vol.36 (3), p.489-491</ispartof><rights>Springer-Verlag Italia 2014</rights><rights>Springer-Verlag Italia 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-af3382b3f898956a016e8679bc6e77e1451eec1c9b2faefed65be7f772c711913</citedby><cites>FETCH-LOGICAL-c442t-af3382b3f898956a016e8679bc6e77e1451eec1c9b2faefed65be7f772c711913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10072-014-1918-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10072-014-1918-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25109815$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cordioli, Cinzia</creatorcontrib><creatorcontrib>De Rossi, Nicola</creatorcontrib><creatorcontrib>Rasia, Sarah</creatorcontrib><creatorcontrib>Lodoli, Giovanni</creatorcontrib><creatorcontrib>Capra, Ruggero</creatorcontrib><title>Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients</title><title>Neurological sciences</title><addtitle>Neurol Sci</addtitle><addtitle>Neurol Sci</addtitle><subject>Adult</subject><subject>Brain - drug effects</subject><subject>Brain - pathology</subject><subject>Early Diagnosis</subject><subject>Female</subject><subject>Humans</subject><subject>Letter to the Editor</subject><subject>Leukoencephalopathy, Progressive Multifocal - chemically induced</subject><subject>Leukoencephalopathy, Progressive Multifocal - diagnosis</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Multiple Sclerosis, Relapsing-Remitting - complications</subject><subject>Multiple Sclerosis, Relapsing-Remitting - drug therapy</subject><subject>Natalizumab - adverse effects</subject><subject>Natalizumab - therapeutic use</subject><subject>Neurology</subject><subject>Neuroradiology</subject><subject>Neurosciences</subject><subject>Neurosurgery</subject><subject>Psychiatry</subject><issn>1590-1874</issn><issn>1590-3478</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kctu1TAQhi0EakvbB2CDLLGBRYonN9tLVJWLdCpY0LXlOOM2xYmD7RSFt-CN8VEOFZtuZkbyN_94_iHkFbALYIy_j_tYFgzqAiSIYn1GTqCRrKhqLp4fahC8PiYvY7xnLJNQHZHjsgEmBTQn5M-VDm6lPSY0afAT1VNPrX7wS9CdQ-qXZPyYs6WTTtoNv5dRd0VApxP2dA7-NmCMwwPScXFpsN5oRx0uPzxOBuc77fys091K33673r2jw0TTL7-xc9aPxmHwcYg0UwNOKZ6RF1a7iOeHfEpuPl59v_xc7L5--nL5YVeYui5ToW1VibKrrJBCNq1m0KJouexMi5wj1A0gGjCyK61Gi33bdMgt56XhkN2qTsmbTTfv8HPBmNR9XnrKIxW0jai4EFJmCjbK5F_GgFbNYRh1WBUwtbdfbUdQ2Vq1P4Jac8_rg_LSjdg_dvxzPQPlBsT8NN1i-G_0k6p_AXkNlpo</recordid><startdate>20150301</startdate><enddate>20150301</enddate><creator>Cordioli, Cinzia</creator><creator>De Rossi, Nicola</creator><creator>Rasia, Sarah</creator><creator>Lodoli, Giovanni</creator><creator>Capra, Ruggero</creator><general>Springer Milan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20150301</creationdate><title>Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients</title><author>Cordioli, Cinzia ; De Rossi, Nicola ; Rasia, Sarah ; Lodoli, Giovanni ; Capra, Ruggero</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-af3382b3f898956a016e8679bc6e77e1451eec1c9b2faefed65be7f772c711913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Brain - drug effects</topic><topic>Brain - pathology</topic><topic>Early Diagnosis</topic><topic>Female</topic><topic>Humans</topic><topic>Letter to the Editor</topic><topic>Leukoencephalopathy, Progressive Multifocal - chemically induced</topic><topic>Leukoencephalopathy, Progressive Multifocal - diagnosis</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Multiple Sclerosis, Relapsing-Remitting - complications</topic><topic>Multiple Sclerosis, Relapsing-Remitting - drug therapy</topic><topic>Natalizumab - adverse effects</topic><topic>Natalizumab - therapeutic use</topic><topic>Neurology</topic><topic>Neuroradiology</topic><topic>Neurosciences</topic><topic>Neurosurgery</topic><topic>Psychiatry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cordioli, Cinzia</creatorcontrib><creatorcontrib>De Rossi, Nicola</creatorcontrib><creatorcontrib>Rasia, Sarah</creatorcontrib><creatorcontrib>Lodoli, Giovanni</creatorcontrib><creatorcontrib>Capra, Ruggero</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cordioli, Cinzia</au><au>De Rossi, Nicola</au><au>Rasia, Sarah</au><au>Lodoli, Giovanni</au><au>Capra, Ruggero</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients</atitle><jtitle>Neurological sciences</jtitle><stitle>Neurol Sci</stitle><addtitle>Neurol Sci</addtitle><date>2015-03-01</date><risdate>2015</risdate><volume>36</volume><issue>3</issue><spage>489</spage><epage>491</epage><pages>489-491</pages><issn>1590-1874</issn><eissn>1590-3478</eissn><cop>Milan</cop><pub>Springer Milan</pub><pmid>25109815</pmid><doi>10.1007/s10072-014-1918-y</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1590-1874 |
ispartof | Neurological sciences, 2015-03, Vol.36 (3), p.489-491 |
issn | 1590-1874 1590-3478 |
language | eng |
recordid | cdi_proquest_journals_1658378899 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Adult Brain - drug effects Brain - pathology Early Diagnosis Female Humans Letter to the Editor Leukoencephalopathy, Progressive Multifocal - chemically induced Leukoencephalopathy, Progressive Multifocal - diagnosis Medicine Medicine & Public Health Multiple Sclerosis, Relapsing-Remitting - complications Multiple Sclerosis, Relapsing-Remitting - drug therapy Natalizumab - adverse effects Natalizumab - therapeutic use Neurology Neuroradiology Neurosciences Neurosurgery Psychiatry |
title | Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T13%3A26%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20detection%20and%20favourable%20outcome%20of%20natalizumab-related%20progressive%20multifocal%20leukoencephalopathy%20(PML)%20in%20two%20multiple%20sclerosis%20patients&rft.jtitle=Neurological%20sciences&rft.au=Cordioli,%20Cinzia&rft.date=2015-03-01&rft.volume=36&rft.issue=3&rft.spage=489&rft.epage=491&rft.pages=489-491&rft.issn=1590-1874&rft.eissn=1590-3478&rft_id=info:doi/10.1007/s10072-014-1918-y&rft_dat=%3Cproquest_cross%3E3605295921%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1658378899&rft_id=info:pmid/25109815&rfr_iscdi=true |